Granahan Investment Management’s CRISPR Therapeutics CRSP Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-52,006	Closed	-$3.4M	–	172
2022 Q3	$3.4M	Buy	52,006 +2,230	+4%	+$162K	0.11%	144
2022 Q2	$3.02M	Sell	49,776 -42,330	-46%	-$2.49M	0.1%	147
2022 Q1	$5.78M	Buy	92,106 +44,565	+94%	+$2.8M	0.14%	127
2021 Q4	$3.6M	Buy	47,541 +2,211	+5%	+$193K	0.07%	164
2021 Q3	$5.07M	Sell	45,330 -5,962	-12%	-$749K	0.1%	149
2021 Q2	$8.3M	Buy	51,292 +3,017	+6%	+$367K	0.15%	125
2021 Q1	$5.88M	Sell	48,275 -8,922	-16%	-$1.35M	0.12%	132
2020 Q4	$8.76M	Buy	57,197 +17,863	+45%	+$2.11M	0.2%	101
2020 Q3	$3.29M	Sell	39,334 -4,291	-10%	-$381K	0.11%	129
2020 Q2	$3.21M	Buy	43,625 +9,498	+28%	+$555K	0.12%	127
2020 Q1	$1.45M	Sell	34,127 -455	-1%	-$23.5K	0.08%	151
2019 Q4	$2.11M	Hold	34,582	–	–	0.1%	139
2019 Q3	$1.42M	Buy	34,582 +2,655	+8%	+$127K	0.08%	150
2019 Q2	$1.5M	Sell	31,927 -730	-2%	-$29.2K	0.07%	155
2019 Q1	$1.17M	Sell	32,657 -2,335	-7%	-$80.7K	0.06%	167
2018 Q4	$1M	Sell	34,992 -12,350	-26%	-$429K	0.07%	165
2018 Q3	$2.1M	Sell	47,342 -47,449	-50%	-$2.48M	0.11%	153
2018 Q2	$5.57M	Buy	94,791 +8,048	+9%	+$458K	0.34%	93
2018 Q1	$3.96M	Sell	86,743 -54,397	-39%	-$2.25M	0.29%	104
2017 Q4	$3.31M	Sell	141,140 -122,606	-46%	-$2.33M	0.26%	116
2017 Q3	$4.71M	Buy	263,746 +89,839	+52%	+$1.63M	0.39%	93
2017 Q2	$2.79M	Buy	+173,907	New	+$2.87M	0.26%	116